TARS NASDAQ
Tarsus Pharmaceuticals, Inc.
1W: -2.6%
1M: +0.0%
3M: -4.7%
YTD: -21.4%
1Y: +41.4%
3Y: +290.6%
5Y: +115.5%
$62.26
-1.22 (-1.92%)
Weekly Expected Move ±6.7%
$54
$58
$62
$67
$71
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$535M
Revenue
+129.0% YoY
$-48M
Net Income
+54.0% YoY
$-32M
Free Cash Flow
+56.7% YoY
94.2%
Gross Margin
-3.8%
Op. Margin
-4.3%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-17.0%
ROA-10.3%
ROIC-202.8%
Valuation
P/E-55.4
P/B7.7
EV/EBITDA-68.8
Leverage
Debt/Equity0.27
Current Ratio3.85
Interest Cov.-6.4x
Quality Scores
Piotroski F5/9
Altman Z8.74
Beneish M-1.89